Bührlen Bernhard
Universitäre Psychiatrische Kliniken Basel, Basel, Schweiz.
Z Evid Fortbild Qual Gesundhwes. 2010;104(10):703-8. doi: 10.1016/j.zefq.2010.10.012. Epub 2010 Oct 30.
Innovation in health care is a complex process taking place within a network of different stakeholders. From their specific perspective they need to continuously assess the technology under consideration to make the necessary decisions about the development and adoption of the technology. This is supported by HTA, but mainly with regard to reimbursement. Other important decisions are far less likely to be underpinned with evidence. The availability of data for both the decision criteria and the structures of decision-making processes have a role in this context. In the present contribution, we discuss the role of HTA in the innovation process. Amendments to assessment criteria, in particular from the perspective of patients, health care professionals, producers and macro-economics, are proposed to improve the basis for decisions of all relevant stakeholder groups.
医疗保健领域的创新是一个在由不同利益相关者组成的网络中发生的复杂过程。从他们各自的特定角度出发，他们需要不断评估所考虑的技术，以便就该技术的开发和采用做出必要的决策。卫生技术评估（HTA）为此提供了支持，但主要是在报销方面。其他重要决策则极不可能有证据支持。决策标准和决策过程结构的数据可用性在此背景下发挥着作用。在本论文中，我们讨论了HTA在创新过程中的作用。我们提出了评估标准的修订建议，特别是从患者、医疗保健专业人员、生产商和宏观经济学的角度，以改善所有相关利益相关者群体的决策依据。
